Morgan Stanley analyst Adahna Ekoku lowered the firm’s price target on Aperam (APEMY) to EUR 29.60 from EUR 30.10 and keeps an Equal Weight rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam Reports Challenging Q1 2025 Financial Results
- Aperam’s Strategic Growth and Sustainability Focus in Q1 2025 Earnings Call
- APEMY Upcoming Earnings Report: What to Expect?
- Aperam price target lowered to EUR 38 from EUR 40 at Deutsche Bank
- Aperam downgraded to Neutral from Outperform at Exane BNP Paribas